Mutual regulation between butyrate and hypoxia-inducible factor-1α in epithelial cell promotes expression of tight junction proteins
- PMID: 32129567
- DOI: 10.1002/cbin.11336
Mutual regulation between butyrate and hypoxia-inducible factor-1α in epithelial cell promotes expression of tight junction proteins
Abstract
Inflammatory bowel disease is a kind of multi-aetiological chronic disease that is driven by multidimensional factors. Hypoxia-inducible factor-1α (HIF-1α) plays an important role in anti-inflammatory and cellular responses to hypoxia. Previous studies have found that B or T-cell-specific HIF-1α knock out mice exhibit severe colonic inflammation. However, we know very little about other functions of HIF-1α in intestinal epithelial cells (IECs). In our study, HIF-1αΔIEC mice were used to study the function of HIF-1α in IECs. HIF-1α was knocked down in Caco-2 cells by transfection with a small interfering (si) RNA. Immunohistochemical staining and western blotting were used to detect the expression of zonula occluden-1 (ZO-1) and Occludin. The content of colon was harvested for high-performance liquid chromatography analysis to examine the levels of butyrate in the gut. Our research found that HIF-1α played a protective role in dextran sulphate sodium-induced colitis, which was partly due to its regulation of tight junction (TJ) protein expression. Further study revealed that HIF-1α mediated TJ proteins levels by moderating the content of butyrate. Moreover, we found that butyrate regulated TJ protein expression, which is dependent on HIF-1α. These results indicated that there is a mutual regulatory mechanism between butyrate and HIF-1α, which has an important role in the maintenance of barrier function of the gastrointestinal tract.
Keywords: butyrate; hypoxia-inducible factor-1α (HIF-1α); intestinal epithelial cell (IEC); tight junction protein (TJ protein).
© 2020 International Federation for Cell Biology.
Similar articles
-
SCFAs induce autophagy in intestinal epithelial cells and relieve colitis by stabilizing HIF-1α.J Mol Med (Berl). 2020 Aug;98(8):1189-1202. doi: 10.1007/s00109-020-01947-2. Epub 2020 Jul 22. J Mol Med (Berl). 2020. PMID: 32696223
-
Hypoxia inducible factor-1α-induced interleukin-33 expression in intestinal epithelia contributes to mucosal homeostasis in inflammatory bowel disease.Clin Exp Immunol. 2017 Mar;187(3):428-440. doi: 10.1111/cei.12896. Epub 2016 Dec 6. Clin Exp Immunol. 2017. PMID: 27921309 Free PMC article.
-
The HIF target ATG9A is essential for epithelial barrier function and tight junction biogenesis.Mol Biol Cell. 2020 Sep 15;31(20):2249-2258. doi: 10.1091/mbc.E20-05-0291. Epub 2020 Jul 29. Mol Biol Cell. 2020. PMID: 32726170 Free PMC article.
-
The role of hypoxia-inducible factor 1-alpha in inflammatory bowel disease.Cell Biol Int. 2022 Jan;46(1):46-51. doi: 10.1002/cbin.11712. Epub 2021 Oct 31. Cell Biol Int. 2022. PMID: 34658125 Review.
-
Oxygen sensing in intestinal mucosal inflammation.Pflugers Arch. 2016 Jan;468(1):77-84. doi: 10.1007/s00424-015-1722-4. Epub 2015 Jul 25. Pflugers Arch. 2016. PMID: 26206140 Review.
Cited by
-
Fatty acids and lipid mediators in inflammatory bowel disease: from mechanism to treatment.Front Immunol. 2023 Oct 5;14:1286667. doi: 10.3389/fimmu.2023.1286667. eCollection 2023. Front Immunol. 2023. PMID: 37868958 Free PMC article. Review.
-
Restoration of dysregulated intestinal barrier and inflammatory regulation through synergistically ameliorating hypoxia and scavenging reactive oxygen species using ceria nanozymes in ulcerative colitis.Biomater Res. 2023 Jul 28;27(1):75. doi: 10.1186/s40824-023-00412-8. Biomater Res. 2023. PMID: 37507801 Free PMC article.
-
LuQi Formula relieves ventricular remodeling through improvement of HIF-1α-mediated intestinal barrier integrity.Chin Med. 2023 Jul 28;18(1):90. doi: 10.1186/s13020-023-00803-y. Chin Med. 2023. PMID: 37507786 Free PMC article.
-
The impact of hypoxia-inducible factors in the pathogenesis of kidney diseases: a link through cell metabolism.Kidney Res Clin Pract. 2023 Sep;42(5):561-578. doi: 10.23876/j.krcp.23.012. Epub 2023 Jun 15. Kidney Res Clin Pract. 2023. PMID: 37448286 Free PMC article.
-
Enhancing intestinal barrier efficiency: A novel metabolic diseases therapy.Front Nutr. 2023 Mar 2;10:1120168. doi: 10.3389/fnut.2023.1120168. eCollection 2023. Front Nutr. 2023. PMID: 36937361 Free PMC article. Review.
References
-
- Albenberg L, Esipova TV, Judge CP, Bittinger K, Chen J, Laughlin A, Grunberg S, Baldassano RN, Lewis JD, Li H, Thom SR, Bushman FD, Vinogradov SA, Wu GD (2014) Correlation between intraluminal oxygen gradient and radial partitioning of intestinal microbiota. Gastroenterology 147: 1055-63.
-
- Capaldo CT, Powell DN, Kalman D (2017) Layered defense: how mucus and tight junctions seal the intestinal barrier. J Mol Med (Berl) 95: 927-34.
-
- Colgan SP, Taylor CT (2010) Hypoxia: an alarm signal during intestinal inflammation. Nat Rev Gastroenterol Hepatol 7: 281-7.
-
- Comerford KM, Wallace TJ, Karhausen J, Louis NA, Montalto MC, Colgan SP (2002) Hypoxia-inducible factor-1-dependent regulation of the multidrug resistance (MDR1) gene. Cancer Res 62: 3387-94.
-
- de Moreno DLA, Del CS, Chatel JM, Miyoshi A, Azevedo V, Langella P, Bermudez-Humaran LG, LeBlanc JG (2015) Current review of genetically modified lactic acid bacteria for the prevention and treatment of colitis using murine models. Gastroenterol Res Pract 2015: 146972.
MeSH terms
Substances
Grants and funding
- cstc2017jcyjAX0234/the Basic Science and Frontier Technology Project of Chongqing
- NSFC 81330013/the National Natural Science Foundation of China
- NSFC 81700454/the National Natural Science Foundation of China
- NSFC81770524/the National Natural Science Foundation of China
- IRT_1716/the Program of Changjiang Scholars and Innovative Research
LinkOut - more resources
Full Text Sources
